Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-016202
Filing Date
2025-02-21
Accepted
2025-02-21 17:34:57
Documents
1
Period of Report
2025-02-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm257316-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm257316-4_4seq1.xml 4 3753
  Complete submission text file 0001104659-25-016202.txt   5213
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Issuer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 200 ROUTE 9 NORTH SUITE 500 MANALAPAN NJ 07726
Business Address
Arnold Mitchell (Reporting) CIK: 0001841497 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39752 | Film No.: 25653391